Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY
Pyott David E I sold 3,830 Alnylam Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Pyott David E I (Director) sold 3,830 Alnylam Pharmaceuticals, Inc. shares at an average US$299.18 for US$1.15M under a trading plan, leaving 1,582 shares. Filed Jun 3, 2026 (Form 4).
- Sold
- 3,830 shares
- Price
- US$299.18 average (US$297.71 to US$302.65)
- Value
- US$1.15M
- Holding after
- 1,582 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 3,830 | 5,412 | Direct | |
| Jun 1, 2026 | Common Stock | Sale | 921 | US$297.71 | 4,491 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 1,175 | US$298.91 | 3,316 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 1,222 | US$299.87 | 2,094 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 495 | US$300.72 | 1,599 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 17 | US$302.65 | 1,582 | Direct |
Source
Related
- Alnylam Pharmaceuticals, Inc.
- Pyott David E I
- Alnylam Pharmaceuticals, Inc. shareholders
- Form 4 · Pyott David E I · May 22, 2026
- Form 4 · Supran Bryan · Oct 6, 2026
- Form 4 · Greenstreet Yvonne · Sep 22, 2026
- Form 4 · Sigal Charles Elliott · May 22, 2026
- Form 4 · Amy Schulman · May 22, 2026
- Form 4 · Reitan Colleen F · May 22, 2026